|
|
||||||||
The Journal of Immunology, Vol 157, Issue 8 3242-3249, Copyright © 1996 by American Association of Immunologists
ARTICLES |
CC Bergmann, Q Yao, CK Ho and SL Buckwold
Department of Neurology, University of Southern California School of Medicine, Los Angeles 90033, USA.
CD8+ CTL responses constitute a critical component for vaccines developed to eliminate intracellular pathogens. One approach to achieve broad CTL diversity is based on genetically linking immunogenic peptides from multiple proteins to form poly-epitope Ags. To address the influence of flanking residues on class I Ag presentation, H-2d- restricted HIV-1 and mouse hepatitis virus CTL epitopes were linked via various spacer residues. The resulting 20 to 31 amino acid peptides were expressed using recombinant vaccinia viruses to monitor both CTL recognition and induction. Our data indicate that recognition is profoundly influenced by the nature of intervening residues forming carboxyl-terminal flanks for one and amino-terminal flanks for the other epitope. Flanking amino acids with aromatic (tyrosine), basic (lysine), and small aliphatic side chains (alanine) supported efficient CTL recognition of both epitopes. By contrast, acidic and helix breaking residues (glycine, proline) specifically inhibited recognition of the adjacent amino-terminal epitope. Flanking residues inhibitory for recognition were also detrimental for CTL induction, suggesting similar processing mechanisms in vitro and in vivo. The ratios of peptide-specific CTL precursors primed by the tandem epitopes varied up to 50-fold depending on molecular context. These data demonstrate a substantial role of carboxyl-flanking residues in governing the efficiency of class I Ag presentation both in vitro and in vivo. The dramatic influence of flanking residues on the hierarchy of CTL responses indicates that CTL induction by poly-epitope Ags can be optimized by strategically linking epitopes via selection of appropriate spacer residues.
This article has been cited by other articles:
![]() |
C. F. Towne, I. A. York, L. B. Watkin, J. S. Lazo, and K. L. Rock Analysis of the Role of Bleomycin Hydrolase in Antigen Presentation and the Generation of CD8 T Cell Responses J. Immunol., June 1, 2007; 178(11): 6923 - 6930. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Daftarian, S. Ali, R. Sharan, S. F. Lacey, C. La Rosa, J. Longmate, C. Buck, R. F. Siliciano, and D. J. Diamond Immunization with Th-CTL Fusion Peptide and Cytosine-Phosphate-Guanine DNA in Transgenic HLA-A2 Mice Induces Recognition of HIV-Infected T Cells and Clears Vaccinia Virus Challenge J. Immunol., October 15, 2003; 171(8): 4028 - 4039. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boissonnas, O. Bonduelle, A. Antzack, Y.-C. Lone, C. Gache, P. Debre, B. Autran, and B. Combadiere In Vivo Priming Of HIV-Specific CTLs Determines Selective Cross-Reactive Immune Responses Against Poorly Immunogenic HIV-Natural Variants J. Immunol., October 1, 2002; 169(7): 3694 - 3699. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Novitsky, H. Cao, N. Rybak, P. Gilbert, M. F. McLane, S. Gaolekwe, T. Peter, I. Thior, T. Ndung'u, R. Marlink, et al. Magnitude and Frequency of Cytotoxic T-Lymphocyte Responses: Identification of Immunodominant Regions of Human Immunodeficiency Virus Type 1 Subtype C J. Virol., September 11, 2002; 76(20): 10155 - 10168. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Z. Wu, J.-P. Zhao, Y. Wan, Z.-C. Jia, W. Zhou, J. Bian, B. Ni, L.-Y. Zou, and Y. Tang Mimovirus: a Novel Form of Vaccine That Induces Hepatitis B Virus-Specific Cytotoxic T-Lymphocyte Responses In Vivo J. Virol., September 11, 2002; 76(20): 10264 - 10269. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Currier, M. deSouza, P. Chanbancherd, W. Bernstein, D. L. Birx, and J. H. Cox Comprehensive Screening for Human Immunodeficiency Virus Type 1 Subtype-Specific CD8 Cytotoxic T Lymphocytes and Definition of Degenerate Epitopes Restricted by HLA-A0207 and -CW0304 Alleles J. Virol., April 16, 2002; 76(10): 4971 - 4986. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Rich and W. R. Green Characterization of the Fas Ligand/Fas-Dependent Apoptosis of Antiretroviral, Class I MHC Tetramer-Defined, CD8+ CTL by In Vivo Retrovirus-Infected Cells J. Immunol., March 15, 2002; 168(6): 2751 - 2758. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lopez, Y. Samino, U. H. Koszinowski, and M. Del Val HIV Envelope Protein Inhibits MHC Class I Presentation of a Cytomegalovirus Protective Epitope J. Immunol., October 15, 2001; 167(8): 4238 - 4244. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lopez, B. C. Gil-Torregrosa, C. Bergmann, and M. Del Val Sequential Cleavage by Metallopeptidases and Proteasomes Is Involved in Processing HIV-1 ENV Epitope for Endogenous MHC Class I Antigen Presentation J. Immunol., May 15, 2000; 164(10): 5070 - 5077. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. X. Y. Mo, S. F. L. van Lelyveld, A. Craiu, and K. L. Rock Sequences That Flank Subdominant and Cryptic Epitopes Influence the Proteolytic Generation of MHC Class I-Presented Peptides J. Immunol., April 15, 2000; 164(8): 4003 - 4010. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Brander, O. O. Yang, N. G. Jones, Y. Lee, P. Goulder, R. P. Johnson, A. Trocha, D. Colbert, C. Hay, S. Buchbinder, et al. Efficient Processing of the Immunodominant, HLA-A*0201-Restricted Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitope despite Multiple Variations in the Epitope Flanking Sequences J. Virol., December 1, 1999; 73(12): 10191 - 10198. [Abstract] [Full Text] |
||||
![]() |
E. Desmézières, Y. Jacob, M.-F. Saron, F. Delpeyroux, N. Tordo, and P. Perrin Lyssavirus glycoproteins expressing immunologically potent foreign B cell and cytotoxic T lymphocyte epitopes as prototypes for multivalent vaccines J. Gen. Virol., September 1, 1999; 80(9): 2343 - 2351. [Abstract] [Full Text] |
||||
![]() |
M. C. Villacres and C. C. Bergmann Enhanced Cytotoxic T Cell Activity in IL-4-Deficient Mice J. Immunol., March 1, 1999; 162(5): 2663 - 2670. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Mylin Context-Dependent Immunogenicity of an S206G-Substituted H-2Db-Restricted Simian Virus 40 Large T Antigen Epitope I Variant J. Immunol., February 15, 1999; 162(4): 2171 - 2179. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Theobald, T. Ruppert, U. Kuckelkorn, J. Hernandez, A. Haussler, E. A. Ferreira, U. Liewer, J. Biggs, A. J. Levine, C. Huber, et al. The Sequence Alteration Associated with a Mutational Hotspot in p53 Protects Cells From Lysis by Cytotoxic T Lymphocytes Specific for a Flanking Peptide Epitope J. Exp. Med., September 21, 1998; 188(6): 1017 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-M. Fu, L. M. Mylin, T. D. Schell, I. Bacik, G. Russ, J. W. Yewdell, J. R. Bennink, and S. S. Tevethia An Endoplasmic Reticulum-Targeting Signal Sequence Enhances the Immunogenicity of an Immunorecessive Simian Virus 40 Large T Antigen Cytotoxic T-Lymphocyte Epitope J. Virol., February 1, 1998; 72(2): 1469 - 1481. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |